Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice

Abstract

A prospective survey was undertaken to determine the prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice. Of the 78 admissions surveyed, 10 patients were confused or too unwell to take part and 25 were pain-free. The remaining 43 reported 86 pains (range 1–6 per patient); of these patients, 27 (63%) had breakthrough pain and identified 52 pains (range 1–5 per patient). Breakthrough pain was classified as somatic (46%) visceral (14%), neuropathic (25%) or mixed aetiology (15%); 60% of pains were severe or excruciating. The mean number of daily breakthrough pain episodes was five (range 1–13), 54% of which occurred suddenly. Most pains (56%) were unpredictable; 75% lasted less than 30 min. These findings suggest that breakthrough pain is common in patients with non-malignant terminal disease; it is frequent, short lasting and often unpredictable, thus making treatment difficult.

Keywords

non-malignant disease breakthrough pain hospice

Get full access to this article

View all access options for this article.

References

World Health Organization . Cancer pain relief, Geneva: WHO, 1986.

Portenoy RK , Hagen NA . Breakthrough pain: definition, prevalence and characteristics. Pain 1990; 41: 273–281.

Fine PG , Busch MA . Characterisation of breakthrough pain by hospice patients and their caregivers. J Pain Symptom Manage 1998; 16: 179–183.

Caraceni A , Portenoy RK . An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 1999; 82: 263–274.

Petzke F , Radbruch L , Zech D , Loick G , Grond S . Temporal presentation of chronic cancer pain: transitory pains on admission to a multidisciplinary pain clinic. J Pain Symptom Manage 1999; 17: 391–401.

Portenoy RK , Payne D , Jacobsen P . Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999; 81: 129–134.

Zeppetella G , O'Doherty C , Collins S . Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage 2000: 20: 87–92.

Seale C . A comparison of hospice and conventional care. Soc Sci Med 1991; 32: 147–152.

Hinton JM . The physical and mental distress of the dying Q Mel J 1963; 32: 1–21.

10.

National Council for Hospice and Specialist Palliative Care . Reaching out: specialist palliative care for adults with non-malignant diseases. Occasional Paper 14, 1998.

11.

Higginson IJ . Epidemiologically-based needs assessment for palliative and terminal care. Leeds: NHS Executive, 1995.

12.

Becker N , Sjøgren P , Bech P , Olsen AK , Eriksen J . Treatment outcome of chronic non-malignant pain patients managed in a Danish multidisciplinary pain centre compared to general practice: a randomised controlled trial. Pain 2000; 84: 203–211.

13.

Simmonds MA . Management of breakthrough pain due to cancer. Oncology 1999; 13: 1103–1114.

14.

Hanks G , Portenoy RK , MacDonald N , Forbes K . Difficult pain problems. In: Doyle D , Hanks GWC MacDonald N eds. Oxford textook of palliative medicine, 2nd edition. Oxford: Oxford University Press, 1998: 454–477.

15.

Mercadante S , Maddaloni S , Roccella S , Salvaggio L . Predictive factors in advanced cancer pain treated only by analgesics. Pain 1992: 50: 151–155.